Anavex Life Sciences Corp. (AVXL)
1.20
-0.02
(-1.64%)
USD |
NASDAQ |
Nov 10, 10:00
Anavex Life Sciences Cash and Short Term Investments (Quarterly) : 118.33M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 118.33M |
| March 31, 2026 | 127.42M |
| December 31, 2025 | 131.75M |
| September 30, 2025 | 102.58M |
| June 30, 2025 | 101.16M |
| March 31, 2025 | 115.77M |
| December 31, 2024 | 120.78M |
| September 30, 2024 | 132.19M |
| June 30, 2024 | 138.76M |
| March 31, 2024 | 139.39M |
| December 31, 2023 | 143.76M |
| September 30, 2023 | 151.02M |
| June 30, 2023 | 154.82M |
| March 31, 2023 | 153.47M |
| December 31, 2022 | 143.62M |
| September 30, 2022 | 149.16M |
| June 30, 2022 | 153.20M |
| March 31, 2022 | 153.34M |
| December 31, 2021 | 151.15M |
| September 30, 2021 | 152.11M |
| June 30, 2021 | 157.56M |
| March 31, 2021 | 75.86M |
| December 31, 2020 | 47.36M |
| September 30, 2020 | 29.25M |
| June 30, 2020 | 27.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.56M |
| December 31, 2019 | 27.46M |
| September 30, 2019 | 22.19M |
| June 30, 2019 | 21.25M |
| March 31, 2019 | 19.46M |
| December 31, 2018 | 20.72M |
| September 30, 2018 | 22.93M |
| June 30, 2018 | 25.83M |
| March 31, 2018 | 25.66M |
| December 31, 2017 | 28.05M |
| September 30, 2017 | 27.44M |
| June 30, 2017 | 24.79M |
| March 31, 2017 | 23.35M |
| December 31, 2016 | 21.16M |
| September 30, 2016 | 9.187M |
| June 30, 2016 | 9.727M |
| March 31, 2016 | 11.95M |
| December 31, 2015 | 13.85M |
| September 30, 2015 | 15.29M |
| June 30, 2015 | 7.961M |
| March 31, 2015 | 6.311M |
| December 31, 2014 | 6.981M |
| September 30, 2014 | 7.262M |
| June 30, 2014 | 8.180M |
| March 31, 2014 | 9.194M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vaxcyte, Inc. | 1.292B |
| Foghorn Therapeutics, Inc. | -- |
| Connect Biopharma Holdings Ltd. | 31.49M |
| Caribou Biosciences, Inc. | 94.80M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |